Scilex Holding SCLX

NASDAQ SCLX
$5.74 +0.09 (+1.59%)
As of: Aug 20, 2026 · 3:59 PM EDT
Financial Ratios
Market Cap39.35 Mn
P/E-0.09
P/S1.24
Div. Yield0.00
ROIC (Qtr)-0.01
Total Debt (Qtr)80.81 Mn
Revenue Growth (1y) (Qtr)-22.81
Add ratio to table…

About

Scilex Holding Co is an innovative revenue generating company focused on acquiring developing and commercializing non opioid pain management products for the treatment of acute and chronic pain. The company markets three FDA approved products ZTlido for postherpetic neuralgia ELYXYB for acute migraine and GLOPERBA for gout prophylaxis. It also has a pipeline of product candidates including SEMDEXA for sciatica SP-103 for acute pain and SP-104 for fibromyalgia. Revenue is…

Read more ↓
Sector: Healthcare Sector rationale The company's primary revenue is generated from the sale of FDA-approved pharmaceutical products (ZTlido, ELYXYB, and GLOPERBA) to wholesalers, pharmacies, and healthcare providers. It also earns revenue from contract manufacturing services and royalties related to these medical products, placing it squarely within the Healthcare sector. Industries: Pharmaceuticals Healthcare Primary Scilex Holding develops and markets branded prescription drugs for pain management, specifically ZTlido for postherpetic neuralgia, ELYXYB for acute migraine, and GLOPERBA for gout prophylaxis. Revenue is generated from the sales of these branded pharmaceutical products to wholesalers and healthcare providers. Contract Manufacturing Healthcare Secondary The company explicitly earns revenue from providing contract manufacturing services in addition to its own product sales. Classified using BQ-MICS CIK: 0001820190

Peer Comparison

Companies in the Drug Manufacturers - General
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 JNJ Johnson & Johnson 645.88 Bn30.706.6049.04 Bn
2 ABBV AbbVie Inc. 463.46 Bn73.387.2070.82 Bn
3 MRK Merck & Co., Inc. 367.92 Bn116.105.5353.91 Bn
4 NVS Novartis Ag 297.71 Bn90.4119.479.59 Bn
5 AZN Astrazeneca Plc 255.55 Bn23.384.1629.49 Bn
6 AMGN Amgen Inc 234.52 Bn26.826.1662.75 Bn
7 GILD Gilead Sciences, Inc. 178.22 Bn-61.565.8528.66 Bn
8 PFE Pfizer Inc 158.57 Bn36.302.4963.19 Bn